Indian firm receives U.S. approval to market Simvastatin, a rival to Merck’s Zocor.
|
Generic drug makers get to keep 180-day exclusivity when the FDA de-lists patents.
|
Generics companies scramble as Merck’s cholesterol-lowering statin loses its patent.
|
Drug company must pay $4.5 million to one of two plaintiffs for causing his heart attack.
|
The New York-based pharma company says it might market torcetrapib on its own.
|
Judge upholds Lipitor patent after challenge from Indian pharma company Ranbaxy.
|
Drug maker is closing five plants in restructuring effort to deal with ongoing Vioxx litigation and other challenges.
|
A jury finds the pharma giant gave doctors adequate warning about Vioxx's risks.
|
Obesity growing beyond developed nations' borders, suggesting cardiovascular problems, and markets, will follow.
|
Despite controversy, the U.S. could follow Britain’s example of making statins available over-the-counter.
|
Scientists say the world’s best-selling medicine is not used widely enough.
|
A study suggests statins should be used more widely; Merck signs an AIDS deal with China and updates pact with Inovio; Cephalon to buy Salmedix; Delcath Systems loses 8 percent; Medicare gets involved in drug safety monitoring.
|
A study shows that Pfizer’s Lipitor may help treat Alzheimer’s disease.
|
A new study shows that men taking statins could be protecting themselves against prostate cancer.
|